Taysha Gene Therapies, Inc. (TSHA) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 282.25M | 324.65M | 299.95M | 316.26M | 120.71M | 142.13M | 161.56M | 178.47M | 130.6M | 149.87M | 171.81M | 54.12M |
| Cash & Short-Term Investments | 276.58M | 319.77M | 297.34M | 312.76M | 116.59M | 139.04M | 157.69M | 172.74M | 123.98M | 143.94M | 164.28M | 45.08M |
| Cash Only | 276.58M | 319.77M | 297.34M | 312.76M | 116.59M | 139.04M | 157.69M | 172.74M | 123.98M | 143.94M | 164.28M | 45.08M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 5.67M | 4.88M | 1.8M | 1.14M | 1.13M | 892K | 914K | 3.26M | 3.28M | 3.42M | 3.13M | 5.7M |
| Total Non-Current Assets | 18.1M | 18.67M | 16.6M | 17.07M | 17.65M | 18.23M | 18.66M | 21.92M | 22.4M | 22.86M | 23.96M | 27.43M |
| Property, Plant & Equipment | 15.61M | 16.18M | 14.27M | 14.73M | 15.31M | 15.87M | 16.29M | 19.48M | 19.95M | 20.41M | 21.02M | 24.49M |
| Fixed Asset Turnover | - | 0.36x | - | 0.13x | 0.15x | 0.13x | 0.10x | 0.06x | 0.17x | 0.17x | 0.21x | 0.10x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 2.31M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.64M |
| Other Non-Current Assets | 2.5M | 183K | 2.33M | 2.34M | 2.34M | 2.37M | 2.37M | 2.44M | 2.46M | 2.46M | 2.94M | 304K |
| Total Assets | 300.35M | 343.32M | 316.55M | 333.33M | 138.36M | 160.36M | 180.22M | 200.39M | 153M | 172.73M | 195.77M | 81.54M |
| Asset Turnover | - | 0.02x | - | 0.01x | 0.02x | 0.01x | 0.01x | 0.01x | 0.02x | 0.02x | 0.03x | 0.03x |
| Asset Growth % | 117.08% | 114.09% | 75.65% | 66.34% | -9.57% | -7.16% | -7.94% | 145.75% | 50.59% | 36.79% | 75.63% | -42.71% |
| Total Current Liabilities | 20.1M | 26.55M | 28.63M | 25.35M | 22.56M | 26.23M | 29.34M | 34.18M | 38.64M | 36.76M | 180.45M | 50.64M |
| Accounts Payable | 4.56M | 6.28M | 5.44M | 7.71M | 4.33M | 3.59M | 4.93M | 8.72M | 10.38M | 6.37M | 7.52M | 10.77M |
| Days Payables Outstanding | - | 1.8K | 2.12K | - | - | - | - | - | - | - | 2.54K | 1.28K |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 5.49M | 7.47M | 9.77M | 11.79M | 13.58M | 14.7M | 18.11M | 18.76M | 20.24M |
| Other Current Liabilities | 15.53M | 10.85M | 7.13M | 5.5M | 3.65M | 6.43M | 5.29M | 4.26M | 3.18M | 4.99M | 144.95M | 15.95M |
| Current Ratio | 14.04x | 12.23x | 10.48x | 12.48x | 5.35x | 5.42x | 5.51x | 5.22x | 3.38x | 4.08x | 0.95x | 1.07x |
| Quick Ratio | 14.04x | 12.23x | 10.48x | 12.48x | 5.35x | 5.42x | 5.51x | 5.22x | 3.38x | 4.08x | 0.95x | 1.07x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 68.31M | 69.83M | 68.93M | 59.26M | 60.75M | 62.61M | 62.09M | 57.35M | 60.51M | 61.04M | 64.43M | 68.02M |
| Long-Term Debt | 17.77M | 18.17M | 50.85M | 41.05M | 42.45M | 43.94M | 42.97M | 37.84M | 40.51M | 40.51M | 38.55M | 38.35M |
| Capital Lease Obligations | 0 | 0 | 16.56M | 16.81M | 17.09M | 17.36M | 17.75M | 18.13M | 18.5M | 18.95M | 19.1M | 19.53M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 50.54M | 51.66M | 1.52M | 1.4M | 1.2M | 1.31M | 1.36M | 1.38M | 1.5M | 1.58M | 3.83M | 3.92M |
| Total Liabilities | 88.41M | 96.38M | 97.56M | 84.6M | 83.3M | 88.84M | 91.42M | 91.53M | 99.15M | 97.79M | 244.88M | 118.66M |
| Total Debt | 17.77M | 18.17M | 69.08M | 59.6M | 61.35M | 63.18M | 62.54M | 57.72M | 60.71M | 61.11M | 59.19M | 59.52M |
| Net Debt | -258.81M | -301.6M | -228.26M | -253.16M | -55.24M | -75.86M | -95.15M | -115.02M | -63.27M | -82.83M | -105.09M | 14.44M |
| Debt / Equity | 0.08x | 0.07x | 0.32x | 0.24x | 1.11x | 0.88x | 0.70x | 0.53x | 1.13x | 0.82x | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -4831.78x | -2358.33x | -2181.20x | -1580.29x | -1132.11x | -852.86x | -1062.50x | -774.11x | -828.69x | 67.96x | -78.60x | -16.08x |
| Total Equity | 211.94M | 246.94M | 218.99M | 248.73M | 55.06M | 71.53M | 88.8M | 108.87M | 53.85M | 74.94M | -49.11M | -37.11M |
| Equity Growth % | 284.94% | 245.25% | 146.62% | 128.47% | 2.25% | -4.55% | 280.8% | 393.33% | 460.24% | 7796.42% | -541.43% | -213.46% |
| Book Value per Share | 0.58 | 0.77 | 0.62 | 0.83 | 0.20 | 0.35 | 0.33 | 0.47 | 0.23 | 0.40 | -0.39 | -0.58 |
| Total Shareholders' Equity | 211.94M | 246.94M | 218.99M | 248.73M | 55.06M | 71.53M | 88.8M | 108.87M | 53.85M | 74.94M | -49.11M | -37.11M |
| Common Stock | 3K | 3K | 3K | 3K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 1K |
| Retained Earnings | -753.71M | -711.3M | -683.45M | -650.72M | -623.83M | -602.3M | -583.52M | -558M | -537.07M | -513.01M | -560.75M | -443.66M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 985K | -192K | -1.14M | -699K | -2.29M | -4.03M | -2.33M | 2.4M | -251K | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |